ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

EQ vs ANIX // RSI-14 & 200D SMA MOMENTUM

Equillium Inc. (NASDAQ) VS. Anixa Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: EQ 0 — ANIX 4
▲ RSI-14 & 200D SMA MOMENTUM LEADER: ANIX
rsi-technicals
43.8
rsi-technicals
56.3
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EQ VS. ANIX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC EQ ANIX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -20.48% -6.25% -14.23 ANIX /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 ANIX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 43.8 56.3 -12.50 ANIX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $107.4M $108.5M -$1.1M ANIX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR EQ REV ANIX REV EQ GROSS % ANIX GROSS % EQ FCF ANIX FCF
FY 2025 $0 $0 — — -$22.8M -$7.2M
FY 2024 $41.1M $210.0K — — -$19.1M -$7.3M
FY 2023 $36.1M $210.0K — — -$21.8M -$6.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EQ // BETA —
ANIX // BETA —